Emerade Device Alert

12-Jul-2019

Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 55-06/18). Pharmaswiss Ceska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle. 

Click here to visit the www.gov.uk website article.


Doctor

Become a BSACI Member...

GPs, Nurses, Allergy Specialists, Dieticians, Generalists

Join BSACI to receive the regular BSACI Allergy Update, have online access to the monthly journal 'Clinical & Experimental Allergy’, download our popular guidelines and a discount to the BSACI Annual Meeting.

Join Now